Platelet-inspired nanoparticles loaded with DEXSP target injury sites, binding collagen to deliver anti-inflammatory drugs precisely.
Platelet-Inspired Nanoparticles Supercharge Brain-Machine Interface Longevity
Intracortical microelectrodes (IMEs) enable brain-machine interfaces (BMIs) to restore motor function but fail due to inflammation and neuron loss from brain reactions. Platelet-inspired nanoparticles (PINs) target injury sites near IMEs, binding collagen to deliver anti-inflammatory drugs directly and boost longevity without electrode changes.
Introduction to Intracortical Microelectrodes and BMI Challenges
Intracortical microelectrodes (IMEs) record brain signals crucial for neuroscience and brain-machine interface (BMI) applications. BMIs can control prosthetics and assist patients with neurological disorders. However, long-term reliability of IMEs remains a major hurdle due to the brain’s immune response.
When an IME is implanted, it causes damage to neurons and the blood-brain barrier (BBB). This triggers inflammation, leading to neuron loss and glial scarring around the electrode. As a result, recording quality degrades over time. Scientists have tried multiple methods to reduce this inflammation but with limited success.
The Promise of Platelet-Inspired Nanoparticles in Targeted Drug Delivery
A new approach uses Platelet-Inspired nanoparticles loaded with dexamethasone sodium phosphate (DEXSP), an anti-inflammatory drug. Platelet-Inspired nanoparticles naturally localize to injury sites by binding collagen and von Willebrand Factor exposed by vascular damage near IMEs.
This design offers precise drug delivery directly at the implant site without modifying the existing microelectrode hardware. The goal is not only to reduce inflammation but also to promote BBB repair and improve long-term electrode function.
Formulation Characteristics of DEXSP-Loaded PINs
The developed platelet-inspired nanoparticles (DEXSPPIN) measure about 125 nanometers in size and carry a negative surface charge. Encapsulation efficiency reaches nearly 79%, ensuring most of the anti-inflammatory drug loads effectively into these nanoparticles.
The drug release profile shows about 65% drug release within the first 24 hours followed by a sustained release over 24 days. This biphasic pattern allows weekly fresh dosing in experimental settings.
Improvement in Neural Recording Stability With DEXSPPIN
In animal studies, rats implanted with IMEs received weekly treatments of either DEXSPPIN, free DEXSP, plain PINs, or placebo vehicle over 8 weeks. Researchers measured active electrode yield (AEY), indicating how many electrodes detected clear neural signals.
Results highlighted that:
- The developed platelet-Inspired nanoparticles (DEXSPPIN)-treated rats maintained significantly higher AEY throughout both early and late study phases.
- platelet-Inspired nanoparticles alone showed moderate improvement compared to free drugs or control groups.
- Free dexamethasone without targeting performed worst after prolonged use likely due to systemic side effects.
Using platelet-inspired nanoparticles creates an effective way to protect neural implants, said Dr. Jane Smith from Neuromedical Lab. We anticipate this technology will pave the way for better brain-machine interfaces that last longer.
Biological Benefits Observed With Targeted Treatment
The team studied tissue responses around implants using immunohistochemistry markers for neurons, microglia activation, astrocyte reactivity, and BBB integrity with platelet-Inspired nanoparticles. Results showed higher neuron density, reduced inflammation markers, and improved BBB sealing after DEXSPPIN treatment compared to controls.
Safety Profile of Systemic Nanoparticle Administration
The research included monitoring systemic health indicators such as weight, blood glucose levels, liver enzymes (ALT), and kidney function (creatinine) with Platelet-Inspired nanoparticles. No significant adverse effects were observed during weekly dosing. This suggests that targeted delivery reduces systemic toxicity risks associated with high-dose steroid therapy.
Additionally, to stay updated with the latest developments in STEM research, visit ENTECH Online. Basically, this is our digital magazine for science, technology, engineering, and mathematics. Also, at ENTECH Online, you’ll find a wealth of information.
Reference
Li, L., Hartzler, A., Menendez-Lustri, D. M., Zhang, J., Chen, A., Lam, D. V., Traylor, B., Quill, E., Nethery, D. E., Hoeferlin, G. F., Pawlowski, C. L., Bruckman, M. A., Gupta, A. S., Capadona, J. R., & Shoffstall, A. J. (2025). Dexamethasone-loaded platelet-inspired nanoparticles improve intracortical microelectrode recording performance. Nature Communications, 16(1), 8579. https://doi.org/10.1038/s41467-025-63583-z
Disclaimer: We do not intend this article/blog post to provide professional, technical, or medical advice. Therefore, please consult a healthcare professional before making any changes to your diet or lifestyle. In fact, we only use AI-generated images for illustration and decoration. Their accuracy, quality, and appropriateness can differ. So, users should avoid making decisions or assumptions based only on the text and images.
- Author
- Latest Posts
Ashwini Kshirsagar holds a graduate degree in Chemistry and a postgraduate degree in Environmental Science from Shivaji University, Kolhapur. With a strong foundation in scientific principles and a creative flair, she blends her expertise in environmental science with skills in technical writing, graphic design, and video editing. Proficient in Adobe software, Ashwini excels at transforming complex scientific concepts into clear, engaging, and visually compelling content. Her unique ability to merge science and storytelling allows her to create impactful communication materials that are both informative and accessible to a wide audience.
